Pax6 is a human neuroectoderm cell fate determinant

Area of Science:

• Developmental Biology
• Stem Cell Biology
• Neuroscience

Background:

• The transcriptional regulation governing neuroectoderm (NE) specification remains largely unknown.
• Understanding early human development is critical for regenerative medicine and disease modeling.

Purpose of the Study:

• To investigate the role of Pax6 in human neuroectoderm specification from human embryonic stem cells (hESCs).
• To compare the function of Pax6 in human versus mouse NE development.

Main Methods:

• Utilized human embryonic stem cells (hESCs) for in vitro differentiation.
• Performed gene knockdown and overexpression studies of Pax6 isoforms (Pax6a, Pax6b, Pax6ΔPD).
• Analyzed gene expression and promoter binding using techniques like chromatin immunoprecipitation.

Main Results:

• Pax6 is uniformly expressed in early human NE cells, contrasting with restricted expression in mouse brain regions.
• Pax6 knockdown inhibits NE specification from hESCs, while overexpression of Pax6a or Pax6b induces differentiation.
• Only Pax6a effectively converts hESCs to NE, and it specifically binds to NE genes during human development.
• Pax6 manipulation did not affect mouse NE specification, highlighting species-specific roles.

Conclusions:

• Pax6 acts as a key transcriptional determinant for human NE specification.
• Pax6a and Pax6b cooperate, differentially targeting pluripotent and NE genes to regulate the transition from pluripotency to the NE fate in humans.